Explore Watchlists Pricing

ABBOTT LABORATORIES (ABT) Balance sheet

Market cap

$165.9B

P/E ratio

25.7x

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2013/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	3,648	6,813	3,475	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896	7,616	8,522
Total cash & short-term investments	3,648	6,813	3,475	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896	7,616	8,522
Accounts receivable, net	7,184	7,684	3,986	3,418	3,248	5,249	5,182	5,425	6,414	6,487	6,218	6,565	6,925	7,929
Inventories	3,189	3,284	2,693	2,599	2,434	3,601	3,796	4,316	5,012	5,157	6,173	6,570	6,194	6,488
Total current assets	22,318	23,769	19,247	14,155	26,776	20,147	14,632	15,667	20,441	24,239	25,224	22,670	23,656	25,996
Property, plant and equipment, net	7,971	7,874	5,905	5,730	5,705	7,607	7,563	8,038	9,029	8,959	9,162	10,154	10,658	11,816
Marketable securities, non-current	302	378	119	4,041	2,947	883	897	883	821	816	766	799	886	918
Total non-current assets	-	-	-	-	-	-	-	10,200	11,700	13,100	14,200	16,200	18,500	22,200
Total assets	59,462	60,277	42,953	41,247	52,666	76,250	67,173	67,887	72,548	75,196	74,438	73,214	81,414	86,713
Long-term debt, current	2,045	1,027	9	3	3	508	7	1,277	7	754	2,251	1,080	1,500	3,033
Total current liabilities	17,262	15,480	9,507	9,186	6,660	8,912	9,012	10,863	11,907	13,105	15,489	13,841	14,157	16,496
Long-term debt, non-current	12,524	12,040	3,388	5,871	20,681	27,210	19,359	16,661	18,527	17,296	14,522	13,599	12,625	9,896
Retained earnings	18,927	20,907	21,979	25,757	25,565	23,978	24,560	25,847	27,627	31,528	35,257	37,554	47,261	49,781
Stockholders' equity	22,476	24,526	25,267	21,326	20,717	31,098	30,722	31,301	33,003	36,024	36,905	38,827	47,901	52,771